Human iPSC-Derived Neural Stem Cells (Male)

axoCells vials

>>> READY TO SHIP PRODUCT

This product has been discontinued. We recommend using our axoCellsTM neural stem cells (ax0004).

Key highlights include:
• Derived from human iPSCs
• Express the typical markers of cerebral cortical neural stem cells (PAX6, FOXG1 and nestin)
• Spontaneously form polarized neural tube-like rosette structures when plated as a monolayer in culture
• Can be differentiated into high-quality cortical excitatory neurons and striatal neurons

Price:

SKU: ax0018
Specifications

Number of cells ≥1.5 million
Donor Male, 74-year-old
Genetics Healthy control

Description

ax0018 Neural Stem Cells are derived from iPSCs generated from a healthy 74-year-old male donor’s pulmonary fibroblasts. They can be further differentiated to generate cortical excitatory neurons or striatal neurons.

Key highlights include:
• Derived from human iPSCs
• Express the typical markers of cerebral cortical neural stem cells (PAX6, FOXG1 and nestin)
• Spontaneously form polarized neural tube-like rosette structures when plated as a monolayer in culture
• Can be differentiated into high-quality cortical excitatory neurons and striatal neurons

axoCells human iPSC-Derived Neural Stem Cells (NSCs) are derived from integration-free, episomally reprogrammed, induced pluripotent stem cells (iPSCs) under fully defined neural induction conditions. AxoCells NSCs are easy to differentiate to neurons or mixed neural cell types, following our protocols and using our tailored media and reagent bundles. We provide Neural Maintenance Media (ax0031), BDNF (ax139800) and GDNF (ax139855) growth factors and NeurOne supplements (ax0674) to drive differentiation to cortical excitatory neurons, as well as Neural Plating Media (ax0033) and optimized SureBond-XF coating (ax0053), all as individual reagents or in kit format with the cells (ax5118). Our cortical excitatory neurons have been specifically developed for use in mono-, co- and tri-culture models of neurodegenerative disease and for drug discovery with microglia (ax0664), astrocytes (ax0704) and inhibitory interneurons (ax0662 or ax0667). We also provide Striatal Neuron Media (ax0333), BDNF (ax139800) and GDNF (ax139855) growth factors and optimized SureBond-XF coating (ax0053) for differentiation of NSCs to striatial neurons as individual products or in kit format with cells (ax3118). The NSCs express typical markers of cerebral cortical neural stem and progenitor cells such as PAX6, FOXG1 and nestin, and spontaneously form polarized neural tube-like rosette structures when plated as a monolayer in culture. Additionally, axoCells NSCs are capable of generating a spectrum of cerebral cortical excitatory and striatal neurons that are electrically active and have the ability to form functional synapses and circuits in vitro. After thawing and plating, the neural stem cells terminally differentiate to acquire mature electrophysiological properties, and form functional synaptic networks over a period of ~ 20 days. Neurons derived from axoCells NSCs can be maintained in culture long-term (>1 year).

Please note: The ethical guidelines for the source material used to generate cell line ax7018 do not provide legal consent for, nor permit, sequencing of any derived cells or materials, including the following products: ax0018, ax0078, ax2508, ax2558, ax2518, ax2568, and ax3078.

Top Resources

No results found.
Additional Information

Cortical Excitatory Neurons

Applications

Our axoCellsTM cortical excitatory neuron progenitors are suitable for investigating Alzheimer’s disease and for screening candidate therapies for this disease.

Healthy control lines are also available and can be used with highcontent imaging, MEA, microfluidic and organ-on-chip (OOC) devices to measure structural and functional responses in neuronal models.

Protocols

Fully optimized cell culture reagents are available for the differentiation of progenitors into mature cortical excitatory neurons within 14 days. In addition, single media protocols, enabling co- and tri-culture of our cortical excitatory neurons with inhibitory interneurons, astrocytes and microglia provide convenient and fast culture solutions to better model human diseases in vitro. 

Quality

We maintain or exceed industry-level quality with our ISO:9001-accredited production facility, guided by our rigorous quality control procedures and decades of scientific experience.  

All cells come with a full Certificate of Analysis and are officially certified by HPSCreg®, to ensure ethical and biological conformity for your peace of mind. 

Licenses & Consent

Axol has obtained all relevant licenses for reprogramming donor samples into iPSCs and differentiating these into cortical excitatory neurons for commercial use.  

Patient samples used to create these neurons have been ethically sourced and consented for research and commercial use. All cells come with a full Certificate of Analysis and are officially certified by HPSCreg®, to ensure ethical and biological conformity for your peace of mind. 

Publications

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498259/ 

Garcia-Leon JA, Vitorica J, & Gutierrez A (2019). Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform. Future Medicinal Chemistry, 11(11), 1305–1322. doi: 10.4155/fmc-2018-0520 [PubMed] [CrossRef] [Google Scholar] 

Striatal Neurons

Data

ICC images of differentiating striatal neural culture. Cells were fixed and stained on day 10day 18 and day 33 for markers of striatal neurons (medium spiny neurons): DARPP32, CTIP2, CALBINDIN, GABA and MAP2.

 

Axol-Bioscience-human-iPSC-image-ir_attachment_85645.png

Applications

Our axoCellsTM striatal neuron progenitors are suitable for investigating Huntington’s disease and for screening candidate therapies for this disease.

Healthy control lines are also available and can be used with highcontent imaging, MEA, microfluidic and organ-on-chip (OOC) devices to measure structural and functional responses in neuronal models.

Protocols

Fully optimized cell culture reagents are available for the differentiation of progenitors into mature striatal neurons within 31 days. In addition, single media protocols, enabling co- and tri-culture of our striatal neurons with inhibitory interneurons, astrocytes and microglia provide convenient and fast culture solutions to better model human diseases in vitro. 

Quality

We maintain or exceed industry-level quality with our ISO:9001-accredited production facility, guided by our rigorous quality control procedures and decades of scientific experience.  

All cells come with a full Certificate of Analysis and are officially certified by HPSCreg®, to ensure ethical and biological conformity for your peace of mind. 

Licenses & Consent

Axol has obtained all relevant licenses for reprogramming donor samples into iPSCs and differentiating these into striatal neurons for commercial use.  

Patient samples used to create these neurons have been ethically sourced and consented for research and commercial use. All cells come with a full Certificate of Analysis and are officially certified by HPSCreg®, to ensure ethical and biological conformity for your peace of mind. 

Publications

Glaser, T., Shimojo, H., Ribeiro, D.E. et al. ATP and spontaneous calcium oscillations control neural stem cell fate determination in Huntington’s disease: a novel approach for cell clock research. Mol Psychiatry 26, 2633–2650 (2021). https://doi.org/10.1038/s41380-020-0717-5

Mathkar, Pranav P. et al. ‘Characterization of Neurodevelopmental Abnormalities in iPSC-Derived Striatal Cultures from Patients with Huntington’s Disease’. Journal of Huntington’s Disease, vol. 8, no. 3, pp. 257-269, 20191 Jan. 2019 : 257 – 269. DOI: 10.3233/JHD-180333

Media and Reagents

Using our kit of specially formulated striatal neuron media ax0333, growth factors BDNF ax139800 and GDNF ax139855, and SureBond–XF coating, mature striatal neurons can be generated in 31 days. We also supply all reagents as standalone items.